Financial Performance - For the three months ended September 30, 2025, total revenue decreased by 3% to $12.4 million, with streaming and digital revenue declining by 5% to $9.6 million [146]. - The company experienced a 39% increase in base distribution revenue for the three months ended September 30, 2025, totaling $1.8 million, primarily due to theatrical releases [146]. - For the six months ended September 30, 2025, total revenue increased by 7% to $23.5 million, with streaming and digital revenue rising by 5% to $18.7 million [154]. - The company reported a net loss attributable to common stockholders of $9.3 million for the three months ended September 30, 2025 [139]. - The company reported a net loss of $9.1 million for the six months ended September 30, 2025, compared to a net loss of $4.3 million in 2024 [165]. - Adjusted EBITDA for the six months ended September 30, 2025, was a loss of $5.8 million, compared to a loss of $0.9 million in the same period of 2024 [165]. Expenses - Direct operating expenses decreased by 17% to $5.2 million for the three months ended September 30, 2025, driven by lower variable costs [150]. - Selling, general and administrative expenses increased by 79% to $11.4 million for the three months ended September 30, 2025, largely due to higher compensation and marketing expenses [151]. - For the six months ended September 30, 2025, total Selling, General and Administrative expenses increased by $7.4 million, or 57%, compared to the same period in 2024, reaching $20.4 million [157]. - Compensation expenses rose by $2.6 million, or 31%, primarily due to an increase in employee headcount [157]. - Marketing expenses surged by $3.3 million, or 7427%, largely attributed to the promotion of Toxic Avenger [157]. - Interest expense decreased by $0.2 million to $0.1 million for the three months ended September 30, 2025, due to a lower average balance on the Line of Credit Facility [153]. - Interest expense decreased by $0.9 million for the six months ended September 30, 2025, primarily due to higher outstanding debt balances and increased interest rates in 2024 [160]. - Amortization of intangible assets increased by $0.5 million, or 31%, during the six months ended September 30, 2025, primarily due to higher capitalized content costs [159]. Cash Flow and Financing - Net cash used in operating activities for the six months ended September 30, 2025, was $21.7 million, compared to $2.4 million in 2024 [166]. - Net cash provided by financing activities increased to $11.0 million for the six months ended September 30, 2025, from $0.5 million in 2024 [166]. - The company has a Line of Credit Facility with East West Bank, allowing borrowings of up to $12.5 million, with $6.6 million outstanding as of September 30, 2025 [140]. - The company plans to continue investing in content development and acquisitions, with short-term content advances of $5.4 million as of September 30, 2025 [141]. Accumulated Deficit and Working Capital - As of September 30, 2025, the company reported an accumulated deficit of $510.2 million and negative working capital of $1.3 million [139].

Financial Data and Key Metrics Changes - Total revenues for Q2 2026 were $12.7 million, down 3% from the prior year quarter, but would have been $13.4 million, up 5%, if a $1.1 million licensing deal for the Toxic Avenger was recognized [5][14] - Operating margins improved by 7% from the prior year quarter to 58% [5] - Net loss for the quarter was $5.5 million, compared to a net loss of $1.2 million in the prior year quarter [15] - Adjusted EBITDA was negative $3.7 million, down from positive $0.5 million in the prior year quarter [15] - Cash and cash equivalents were $2.3 million as of September 30, with $5.9 million available on a $12.5 million working capital facility [15][16] Business Line Data and Key Metrics Changes - The performance of the Toxic Avenger Unrated was below expectations at the box office, but it is expected to be profitable with an IRR of 40% due to strong ancillary distribution [6][9] - The company continues to focus on controlling costs and leveraging efficiencies from Cineverse Services India to manage SG&A spending [6] - The upcoming releases, Silent Night Deadly Night and Return to Silent Hill, are projected to follow a similar low-cost investment strategy [9] Market Data and Key Metrics Changes - Total streaming viewers reached 143.8 million, up 47% year over year, with total minutes streamed at 3.4 billion, up 45% [18] - SVOD subscribers grew to 1.39 million, a 6% increase year over year [18] - The Cineverse branded channel grew more than 6,400% in viewership since its relaunch in January [19] Company Strategy and Development Direction - The company is focusing on a fan-centric, IP-based film strategy, avoiding mixed-genre films in the future [31] - The Match Point technology sales pipeline is expanding, with dozens of potential partners actively evaluating the technology [12][23] - The MicroCo joint venture aims to become a leader in the micro-drama market, which is expected to represent a significant portion of streaming viewing time [24][25] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence that investments made in sales, marketing, and technology will yield strong results in the remainder of the fiscal year and beyond [15][17] - The advertising environment is mixed, but there is optimism for growth as political spending ramps up in Q4 [20][21] - The company believes it is well-positioned for future growth with multiple engines of growth supported by technology and a growing audience [26] Other Important Information - The content library is now valued at $45 million, significantly above the $3.2 million book value [12][16] - The company is actively seeking strategic partnerships and acquisitions to enhance its technology offerings [24][40] Q&A Session Summary Question: Impact of Toxic Avenger's performance on future slate - Management believes the performance validated their theatrical releasing strategy and will influence future film selections to avoid mixed-genre movies [30][31] Question: Timing of monetization for Match Point - Management indicated that while the sales cycle is longer, there is strong interest from studios, and they expect significant revenue contributions in the next 12-24 months [32][33]

Financial Performance - Total revenue for Q2 FY 2026 was $12.4 million, a 3% decrease from $12.7 million in the prior-year quarter[4] - Net loss attributable to common stockholders was $(5.7) million, or $(0.31) per share, compared to a net loss of $(1.4) million, or $(0.09) per share, in the prior-year quarter[7] - Total revenues for the three months ended September 30, 2025, were $12,357,000, a decrease of 3% compared to $12,739,000 for the same period in 2024[31] - Operating loss for the three months ended September 30, 2025, was $(5,410,000), compared to $(861,000) for the same period in 2024, reflecting a significant increase in losses[31] - Net loss attributable to common stockholders for the three months ended September 30, 2025, was $(5,678,000), compared to $(1,376,000) for the same period in 2024, indicating a worsening financial performance[31] - Adjusted EBITDA for the three months ended September 30, 2025, was $(3,685,000), compared to $532,000 for the same period in 2024, showing a decline in operational performance[36] - The company reported a net loss before income taxes of $(5,525,000) for the three months ended September 30, 2025, compared to $(1,197,000) for the same period in 2024, reflecting deteriorating profitability[31] Operating Expenses - SG&A expenses rose by $5.0 million, or 79%, to $11.4 million, driven by increased marketing costs and compensation[5] - Selling, general and administrative expenses for the three months ended September 30, 2025, were $11,407,000, a substantial increase from $6,364,000 for the same period in 2024, indicating rising operational costs[31] Assets and Liabilities - Total current assets decreased to $23,258,000 as of September 30, 2025, from $38,081,000 as of March 31, 2025, indicating a liquidity challenge[29] - Total liabilities decreased to $24,784,000 as of September 30, 2025, from $34,724,000 as of March 31, 2025, reflecting a reduction in financial obligations[29] - Cash and cash equivalents significantly decreased to $2,336,000 as of September 30, 2025, from $13,941,000 as of March 31, 2025, highlighting cash flow issues[29] - Total stockholders' equity decreased to $37,163,000 as of September 30, 2025, from $37,792,000 as of March 31, 2025, indicating a decline in shareholder value[29] Revenue Streams - Streaming and digital revenues decreased by 5% to $9.6 million from $10.1 million in the prior year[6] Strategic Initiatives - Cineverse announced a new venture, MicroCo, projected to tap into a $10 billion market by 2027[10] - The company plans to reissue the 20th anniversary edition of Pan's Labyrinth in Fall 2026, with a marketing campaign starting at the Cannes Film Festival[3] - Cineverse's Matchpoint™ platform added over 20 new customers in the last 100 days, indicating strong momentum in technology partnerships[17] Content Valuation - The company's content library, valued at $45 million, significantly exceeds its book value of $3.2 million[16] - The Toxic Avenger Unrated is projected to generate an internal rate of return (IRR) of over 40% despite underperforming at the box office[2]

Core Insights - Cineverse Corp. reported total revenue of $12.4 million for Q2 FY 2026, a 3% decline year-over-year, primarily due to timing differences in revenue recognition for content licensing agreements [1][4][12] - The direct operating margin improved by 7 percentage points to 58% compared to the prior-year quarter, indicating solid performance across core business lines despite the revenue decline [2][13] - The company experienced a net loss of $(5.7) million, or $(0.31) per share, compared to a net loss of $(1.4) million, or $(0.09) per share, in the prior-year quarter [6][28] Financial Performance - Total quarterly revenue was $12.4 million, down from $12.7 million in the prior-year quarter, driven by gains in streaming, digital distribution, and theatrical sales [4] - Streaming and digital revenues decreased by 5% to $9.6 million, while base distribution revenue increased by 39% to $1.8 million, primarily due to the theatrical release of The Toxic Avenger Unrated [8] - SG&A expenses rose by 79% to $11.4 million, reflecting increased marketing costs and investments in the theatrical slate and technology group [5] Operational Developments - Cineverse announced the reissue of the 20th anniversary edition of Pan's Labyrinth, with a marketing campaign set to kick off at the Cannes Film Festival in May 2026 [3][16] - The company is advancing its MicroCo venture, a new studio for microseries, projected to reach a market size of $10 billion by 2027 [14][19] - The Toxic Avenger Unrated is projected to generate an internal rate of return (IRR) of over 40%, despite underperforming at the box office [2][15] Strategic Initiatives - Cineverse is expanding its technology partnerships and has signed four new customers for its Matchpoint™ media supply chain platform [18] - The company continues to build its content library, which is valued at $45 million, significantly above its book value of $3.2 million [9][17] - Management emphasizes a focus on profitability while pursuing growth through strategic partnerships and technology advancements [21]

Core Insights - Cineverse Corp. is a streaming technology and entertainment company that offers various streaming services, including SVOD, AVOD, and FAST channels, and recently rebranded from Cinedigm Corp. [1] - The consensus price target for Cineverse has remained steady at $9, indicating a stable outlook from analysts regarding the company's performance in the streaming sector [2][6] - Recent discussions during the Q1 2026 earnings call may provide insights into how the rebranding could influence future growth and market presence [3][6] - Technological advancements are crucial for enhancing Cineverse's competitive position in the streaming market [4][6] - Content partnerships and acquisitions are vital for expanding Cineverse's content library, which could attract more subscribers and boost revenue growth [5][6]

Core Insights - Cineverse (Nasdaq: CNVS) is establishing itself as a leader in the entertainment industry by signing new customers for its automated video content management platform, Matchpoint [1][2] - The company is experiencing strong market traction and interest in its technology, particularly in the streaming services sector [2][4] - Matchpoint has seen significant adoption over the past year, with various media companies recognizing its value in addressing streaming challenges [2][4] Company Developments - Cineverse Technology Group, formed in May, is leveraging its proprietary technology to enhance video streaming and content management [3][6] - The company launched Matchpoint 3.0, the most advanced version of its platform, and introduced several new streaming channels powered by Matchpoint [4][5] - Strategic partnerships have been established with various media entities, including APTN, The Asylum, and Rockbot, to enhance content delivery and expand channel offerings [3][4] Market Expansion - Cineverse is expanding its lineup of streaming channels through FAST distribution deals, indicating a broader reach in the entertainment market [2][4] - The company has made significant advancements in AI technology, including the introduction of cineSearch, an AI-powered search and discovery tool [5][6] - New in-car entertainment capabilities and partnerships with Symphony AI have been announced, showcasing the company's commitment to innovation [4][5] Financial Performance - Cineverse is set to report its second-quarter fiscal results on November 14, 2025, indicating ongoing financial transparency and engagement with investors [8]

Core Insights - Cineverse Corp. will release its financial results for the fiscal second quarter ended September 30, 2025, after market close on November 14, 2025 [1] - A conference call to discuss these results will be held on the same day at 4:30 p.m. ET/1:30 p.m. PT, accessible online [2] - An audio recording of the conference call will be available for replay shortly after its completion [3] Company Overview - Cineverse is a next-generation entertainment studio that empowers creators and entertains fans with a wide range of content through technology [4] - The company distributes over 71,000 premium films, series, and podcasts, connecting fans with independent stories [4] - Cineverse's properties include the highest-grossing unrated film in U.S. history and a premier podcast network, among others [4]

Core Points - Cineverse has announced a live performance by legendary filmmaker and composer John Carpenter on Halloween night, October 31, 2025, which will be streamed worldwide [1][2] - This event marks Carpenter's first public performance since 2018 and will feature him performing iconic themes and fan favorites [2][3] - The performance will be available for global streaming through VEEPS.com, with Screambox subscribers in the U.S. able to access it live [4] Company Overview - Cineverse (Nasdaq: CNVS) is a next-generation entertainment studio that focuses on delivering innovative content and experiences [1][10] - Bloody Disgusting, a division of Cineverse, serves horror fans through various media, including streaming services and merchandise [10] - VEEPS, a part of Live Nation Entertainment, is a leading platform for live music streaming, connecting fans with artists through live performances [11] Event Details - The event titled "JOHN CARPENTER LIVE: HALLOWEEN FROM LOS ANGELES" will be captured in front of a live audience in Downtown L.A. [2] - Carpenter will be joined on stage by longtime collaborators Cody Carpenter and Daniel Davies [3] - Ticket access for the livestream will be available globally, marking the first live streaming event on Screambox [4]

Core Viewpoint - Benchmark analyst Daniel Kurnos has lowered the price target for Cineverse (CNVS) to $9 from $10 while maintaining a Speculative Buy rating on the shares, indicating a cautious outlook on the company's future performance [1]. Financial Adjustments - The firm has adjusted its EBITDA forecast for Cineverse down by $5 million, reflecting a reset of expectations for the company's financial performance this year [1]. Revenue Expectations - The analyst expressed that the previous expectations for revenue and profitability from the newly acquired film slate were overly optimistic, particularly in comparison to the success of Terrifier 3 [1].

Core Viewpoint - Purcell & Lefkowitz LLP is investigating Palisade Bio, Inc. to determine if the company's directors breached their fiduciary duties related to recent corporate actions [1]. Group 1 - The investigation is being conducted on behalf of Palisade Bio's shareholders [1]. - Shareholders interested in more information about their rights and options can contact Purcell & Lefkowitz LLP [2]. - The law firm specializes in representing shareholders affected by securities fraud and breaches of fiduciary duty [3].